Schwab Charles Investment Management Inc. Has $5.32 Million Stake in Proto Labs, Inc. (PRLB)
Schwab Charles Investment Management Inc. increased its position in Proto Labs, Inc. (NYSE:PRLB) by 4.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 104,131 shares of the industrial products company’s stock after buying an additional 4,342 shares during the period. Schwab Charles Investment Management Inc. owned 0.39% of Proto Labs worth $5,322,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of the company. Victory Capital Management Inc. boosted its stake in Proto Labs by 65.6% in the first quarter. Victory Capital Management Inc. now owns 1,974 shares of the industrial products company’s stock valued at $101,000 after buying an additional 782 shares in the last quarter. Ameritas Investment Partners Inc. acquired a new stake in Proto Labs during the first quarter valued at approximately $109,000. UBS Group AG boosted its stake in Proto Labs by 128.0% in the first quarter. UBS Group AG now owns 2,603 shares of the industrial products company’s stock valued at $133,000 after buying an additional 11,895 shares in the last quarter. State of Alaska Department of Revenue boosted its stake in Proto Labs by 2.3% in the first quarter. State of Alaska Department of Revenue now owns 2,690 shares of the industrial products company’s stock valued at $137,000 after buying an additional 60 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Proto Labs by 27.1% in the first quarter. SG Americas Securities LLC now owns 2,830 shares of the industrial products company’s stock valued at $145,000 after buying an additional 603 shares in the last quarter.
Shares of Proto Labs, Inc. (NYSE PRLB) remained flat at $74.00 during midday trading on Tuesday. 11,725 shares of the company were exchanged. Proto Labs, Inc. has a 52-week low of $43.10 and a 52-week high of $75.25. The firm has a market cap of $1.97 billion, a PE ratio of 43.02 and a beta of 0.93. The stock has a 50-day moving average of $68.79 and a 200-day moving average of $59.11.
Proto Labs (NYSE:PRLB) last released its quarterly earnings results on Thursday, July 27th. The industrial products company reported $0.49 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.06. The business had revenue of $82.04 million during the quarter, compared to analyst estimates of $80.49 million. Proto Labs had a return on equity of 11.75% and a net margin of 14.59%. Proto Labs’s quarterly revenue was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.45 EPS. On average, equities analysts forecast that Proto Labs, Inc. will post $2.06 EPS for the current year.
TRADEMARK VIOLATION NOTICE: This piece of content was posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was illegally copied and republished in violation of international copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2017/08/08/schwab-charles-investment-management-inc-has-5-32-million-stake-in-proto-labs-inc-prlb.html.
Several research firms recently commented on PRLB. Piper Jaffray Companies reaffirmed a “hold” rating and set a $67.00 target price on shares of Proto Labs in a research note on Friday, July 28th. Zacks Investment Research cut Proto Labs from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, June 28th. Dougherty & Co raised Proto Labs from a “sell” rating to a “neutral” rating in a research note on Tuesday, June 27th. Finally, TheStreet raised Proto Labs from a “c+” rating to a “b-” rating in a research note on Friday, May 5th. Four equities research analysts have rated the stock with a hold rating, Proto Labs has a consensus rating of “Hold” and an average target price of $60.75.
In other Proto Labs news, VP Robert Bodor sold 741 shares of the company’s stock in a transaction that occurred on Thursday, July 27th. The stock was sold at an average price of $73.84, for a total transaction of $54,715.44. Following the transaction, the vice president now owns 17,319 shares in the company, valued at approximately $1,278,834.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Rainer Gawlick sold 833 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $64.05, for a total value of $53,353.65. Following the transaction, the director now owns 6,258 shares in the company, valued at approximately $400,824.90. The disclosure for this sale can be found here. Insiders have sold a total of 4,833 shares of company stock valued at $342,782 in the last ninety days. 7.78% of the stock is currently owned by corporate insiders.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
Want to see what other hedge funds are holding PRLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Proto Labs, Inc. (NYSE:PRLB).
Receive News & Ratings for Proto Labs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.